Gray JA, Zito K, and Hell JW (2016). Non-ionotropic signaling by the NMDA receptor: controversy and opportunity. F1000 Research, 5(F1000 Faculty Rev): 1010. PDF

Stein IS, Gray JA, and Zito K (2015). Non-ionotropic NMDA receptor signaling drives activity-induced dendritic spine shrinkage. Journal of Neuroscience, 35(35): 12303-12308. PDF

Sanz-Clemente A, Gray JA, Nicoll RA, and Roche KW (2013). Activated CaMKII couples GluN2B and Casein Kinase 2 to control synaptic NMDA receptors. Cell Reports, 3(3): 607-614. PDF

Gray JA and Nicoll RA (2012). Thinking outside the synapse: glycine at extrasynaptic NMDA receptors. Cell, 150(3): 455-456. PDF

Chen BS*, Gray JA*, Sanz-Clemente A, Wei Z, Thomas EV, Nicoll RA, and Roche KW (2012). SAP102 mediates synaptic clearance of NMDA receptors. Cell Reports, 2(5): 1120-1128. (*co-first authors) PDF

Gray JA (2012). Parkinsonism and rabbit syndrome following discontinuation of low-dose ziprasidone and concomitant initiation of sertraline. Journal of Clinical Psychopharmacology, 32(1): 142-143. PDF

Gray JA, Shi Y, Usui H, During MJ, Sakimura K, Nicoll RA (2011). Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron, 71(6): 1085-1101. PDF

Granger AJ, Gray JA, Lu W, and Nicoll RA (2011). Genetic analysis of neuronal ionotropic glutamate receptor subunits. Journal of Physiology, 589(17): 4095-4101. PDF

Lu W*, Gray JA*, Granger AJ, During MJ, Nicoll RA (2011). The potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunit. Journal of Neurophysiology, 105(2): 923-928. (*co-first authors) PDF

Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y (2010). Metabolic control of vesicular glutamate transport and release. Neuron, 68(1): 99-112. PDF

Gray JA and Risch SC (2009). When clozapine is not enough. Augment with lamotrigine? Current Psychiatry, 8(1): 41-46. PDF

Berger M, Gray JA, and Roth BL (2009). The expanded biology of serotonin. Annual Review of Medicine, 60: 355-366. PDF

Gray JA and Roth BL (2007). The pipeline and future of drug development in schizophrenia. Molecular Psychiatry, 12(10): 904-922. PDF

Gray JA and Roth BL (2007). Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophrenia Bulletin, 33(5): 1100-1119. PDF

Gray JA and Roth BL (2006). Developing selectively non-selective drugs for treating CNS disorders. Drug Discovery Today: Therapeutic Strategies, 3(4): 413-419. PDF

Xia Z, Hufeisen SJ, Gray JA, and Roth BL (2003). The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience, 122(4): 907-920. PDF

Gray JA, Compton-Toth BA, and Roth BL (2003). Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization. Biochemistry, 42(36): 10853-10862. PDF

Xia Z, Gray JA, Compton-Toth BA, and Roth BL (2003). A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. Journal of Biological Chemistry 278(24): 21901-21908. PDF

Gray JA, Bhatnagar A, Gurevich VV, and Roth BL (2003). The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT2A receptor induces agonist-independent internalization. Molecular Pharmacology 63(5): 961-972. PDF

Gray JA and Roth BL (2002). A Last GASP for GPCRs? Science 297: 529-531. PDF

Gray JA, Sheffler DJ, Bhatnagar A, Woods JA, Hufeisen SJ, Benovic JL, and Roth BL (2001). Cell-type specific effects of endocytosis inhibitors on 5-HT2A receptor desensitization and resensitization reveal an arrestin-, GRK2- and GRK5-independent mode of regulation in HEK-293 cells. Molecular Pharmacology 60(5): 1020-1030. PDF

Gray JA and Roth BL (2001). Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists. Brain Research Bulletin 56(5): 441-451. PDF

Bhatnagar A, Willins DL, Gray JA, Woods JA, Benovic JL, and Roth BL (2001). The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. Journal of Biological Chemistry 276(11): 8269-8277. PDF

Gelber EI, Kroeze WK, Willins DL, Gray JA, Sinar CA, Hyde EG, Gurevich V, Benovic JL, and Roth BL (1999). Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins. Journal of Neurochemistry 72: 2206-2214. PDF

 

Book Chapters

Gray JA (2017). Introduction to the Pharmacology of CNS Drugs, in Basic and Clinical Pharmacology 14E. Katzung BG (Ed.), McGraw-Hill, New York, NY, in press.

Gray JA and Roth BL (2017). Intraneuronal Signaling, in Kaplan & Sadock’s Comprehensive Textbook of Psychiatry – Tenth Edition. Sadock BJ, Sadock VA and Ruiz P (Eds.) Lippincott Williams & Wilkins, Philadelphia, PA, pp 119-130.

Gray JA (2017). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2018. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1251.

Gray JA (2016). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2017. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1247.

Gray JA (2015). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2016. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1198.

Gray JA and Nicoll RA (2014). Introduction to the Pharmacology of CNS Drugs, in Basic and Clinical Pharmacology 13E. Katzung BG (Ed.), McGraw-Hill, New York, NY, pp 355-368.

Gray JA (2014). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2015. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1148.

Gray JA (2013). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2014. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1078.

Gray JA (2012). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2013. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 1067.

Gray JA (2011). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2012. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 997.

Gray JA (2010). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2011. Ferri FF (Ed.), Mosbi, Philadelphia, PA, pp 1069-1070.

Gray JA and Roth BL (2009). Intraneuronal Signaling, in Kaplan & Sadock’s Comprehensive Textbook of Psychiatry – Ninth Edition. Sadock BJ, Sadock VA and Ruiz P (Eds.) Lippincott Williams & Wilkins, Philadelphia, PA, pp 118-129.

Gray JA and Lai A (2009). Tardive Dyskinesia, in Ferri’s Clinical Advisor 2010. Ferri FF (Ed.), Mosbi, Philadelphia, PA, p 976.

Gray JA and Roth BL (2007). Serotonin Systems, in Handbook of Contemporary Neuropharmacology. Sibley DR, Hanin I, Kuhar M and Skolnick P (Eds.), John Wiley & Sons, New York, NY, pp 257-298.